Global Pharyngitis Tablets Market
Global Pharyngitis Tablets Market

Pharyngitis Tablets Comprehensive Study by Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies), Source (Viral, Bacterial), Symptoms (Sore Throat, Fever, Runny Nose, Cough, Headache, Hoarse Voice) Players and Region - Global Market Outlook to 2026

Pharyngitis Tablets Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Feb 2021 Edition 240 Pages 216 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Pharyngitis Tablets Market Overview:
Pharyngitis is refer as the medical condition which causes the inflammation at the back of the throat refer as pharynx or sour throat. Pharyngitis sometimes also leads to difficulty and itchiness in swallowing. There are some of the viral and bacterial agents which causes pharyngitis, majority of it includes measles, croup, whooping cough, adenovirus, chickenpox, and group A streptococcus. Pharyngitis is basically caused by viral infection such as common cold, mononucleosis, and influenza. The most common bacterial infection is strep throat which is caused by group A streptococcus. The other common symptoms of pharyngitis includes sneezing, fatigue, body aches, runny nose, headache, cough, chills, and fever. Pharyngitis tablets are used for the treatment of sour throat that is pharyngitis.

Growth Drivers
  • Increase in the prevalence of pharyngitis globally
  • Developing healthcare infrastructure and high disposable income
  • High investment of the Government for the Research & Development (R&D) of novel therapies and drugs to treat pharyngitis

Market Trends
  • The immense pace of R&D activities due to the presence of large biotechnology and pharmaceutical companies

Roadblocks
  • Recent expiries of patented drugs, generic drugs that are available for the treatment are anticipated to hamper the growth of the market

Opportunities
  • Technological advancement in the diagnosis of pharyngitis leading to patented drugs for treatment is providing an opportunity for the market

Challenges
  • Cost factor associated with the treatment of pharyngitis is posing a challenge for the market


Competitive Landscape:
The market appears to be fragmented due to a large number of players in the market who are heavily investing in R&D for the development of novel therapies and drugs to treat pharyngitis. Moreover, regulatory bodies of the healthcare sector are paying more attention on novel drugs by giving faster approvals and special status for the drugs.
Some of the key players profiled in the report are GSK group of companies (United Kingdom), Pfizer Inc. (United States), Genentech Inc. (United States), McNeil (United States), Adamas Pharmaceutical Inc. (United States), PLIVA HRVATSKA d.o.o. (Croatia), Valeant Pharmaceuticals International, Inc. (Canada), Mylan N.V. (United States), Teva Pharmaceutical Industries Ltd. (Israel) and AbbVie Inc. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Pharyngitis Tablets market by 2026. Considering Market by Distribution Channel, the sub-segment i.e. Hospitals will boost the Pharyngitis Tablets market. Considering Market by Source, the sub-segment i.e. Viral will boost the Pharyngitis Tablets market. Considering Market by Symptoms, the sub-segment i.e. Sore Throat will boost the Pharyngitis Tablets market.

According to the American Osteopathic Association (AOA), pharyngitis induced sore throat in one of the leading reasons for physician visits in the United States. Viral infection such as common cold, influenza, and mononucleosis are some of the most common causes of sore throat. According to the World Health Organization, around 3-5 million cases of severe flu are recorded every year worldwide and between 2, 50,000 to 3, 00,000 deaths occur.

Available Customization:
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Pharyngitis Tablets market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Pharyngitis Tablets market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Pharmaceutical Companies, Healthcare Industry, Government and Regulatory Bodies and Distributor, Suppliers, Traders of Pharyngitis Tablet Manufacturers.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.
Report Objectives / Segmentation Covered
By Distribution Channel
  • Hospitals
  • Retail Pharmacies
  • Online Pharmacies

By Source
  • Viral
  • Bacterial

By Symptoms
  • Sore Throat
  • Fever
  • Runny Nose
  • Cough
  • Headache
  • Hoarse Voice

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increase in the prevalence of pharyngitis globally
      • 3.2.2. Developing healthcare infrastructure and high disposable income
      • 3.2.3. High investment of the Government for the Research & Development (R&D) of novel therapies and drugs to treat pharyngitis
    • 3.3. Market Challenges
      • 3.3.1. Cost factor associated with the treatment of pharyngitis is posing a challenge for the market
    • 3.4. Market Trends
      • 3.4.1. The immense pace of R&D activities due to the presence of large biotechnology and pharmaceutical companies
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Pharyngitis Tablets, by Distribution Channel, Source, Symptoms and Region (value) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Pharyngitis Tablets (Value)
      • 5.2.1. Global Pharyngitis Tablets by: Distribution Channel (Value)
        • 5.2.1.1. Hospitals
        • 5.2.1.2. Retail Pharmacies
        • 5.2.1.3. Online Pharmacies
      • 5.2.2. Global Pharyngitis Tablets by: Source (Value)
        • 5.2.2.1. Viral
        • 5.2.2.2. Bacterial
      • 5.2.3. Global Pharyngitis Tablets by: Symptoms (Value)
        • 5.2.3.1. Sore Throat
        • 5.2.3.2. Fever
        • 5.2.3.3. Runny Nose
        • 5.2.3.4. Cough
        • 5.2.3.5. Headache
        • 5.2.3.6. Hoarse Voice
      • 5.2.4. Global Pharyngitis Tablets Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
  • 6. Pharyngitis Tablets: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. GSK group of companies (United Kingdom)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer Inc. (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Genentech Inc. (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. McNeil (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Adamas Pharmaceutical Inc. (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. PLIVA HRVATSKA d.o.o. (Croatia)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Valeant Pharmaceuticals International, Inc. (Canada)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Mylan N.V. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Teva Pharmaceutical Industries Ltd. (Israel)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. AbbVie Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Pharyngitis Tablets Sale, by Distribution Channel, Source, Symptoms and Region (value) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Pharyngitis Tablets (Value)
      • 7.2.1. Global Pharyngitis Tablets by: Distribution Channel (Value)
        • 7.2.1.1. Hospitals
        • 7.2.1.2. Retail Pharmacies
        • 7.2.1.3. Online Pharmacies
      • 7.2.2. Global Pharyngitis Tablets by: Source (Value)
        • 7.2.2.1. Viral
        • 7.2.2.2. Bacterial
      • 7.2.3. Global Pharyngitis Tablets by: Symptoms (Value)
        • 7.2.3.1. Sore Throat
        • 7.2.3.2. Fever
        • 7.2.3.3. Runny Nose
        • 7.2.3.4. Cough
        • 7.2.3.5. Headache
        • 7.2.3.6. Hoarse Voice
      • 7.2.4. Global Pharyngitis Tablets Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Pharyngitis Tablets: by Distribution Channel(USD Million)
  • Figure 4. Global Pharyngitis Tablets: by Distribution Channel USD Million (2015-2020)
  • Table 2. Pharyngitis Tablets Hospitals , by Region USD Million (2015-2020)
  • Table 3. Pharyngitis Tablets Retail Pharmacies , by Region USD Million (2015-2020)
  • Table 4. Pharyngitis Tablets Online Pharmacies , by Region USD Million (2015-2020)
  • Table 5. Pharyngitis Tablets: by Source(USD Million)
  • Figure 5. Global Pharyngitis Tablets: by Source USD Million (2015-2020)
  • Table 6. Pharyngitis Tablets Viral , by Region USD Million (2015-2020)
  • Table 7. Pharyngitis Tablets Bacterial , by Region USD Million (2015-2020)
  • Table 8. Pharyngitis Tablets: by Symptoms(USD Million)
  • Figure 6. Global Pharyngitis Tablets: by Symptoms USD Million (2015-2020)
  • Table 9. Pharyngitis Tablets Sore Throat , by Region USD Million (2015-2020)
  • Table 10. Pharyngitis Tablets Fever , by Region USD Million (2015-2020)
  • Table 11. Pharyngitis Tablets Runny Nose , by Region USD Million (2015-2020)
  • Table 12. Pharyngitis Tablets Cough , by Region USD Million (2015-2020)
  • Table 13. Pharyngitis Tablets Headache , by Region USD Million (2015-2020)
  • Table 14. Pharyngitis Tablets Hoarse Voice , by Region USD Million (2015-2020)
  • Table 15. South America Pharyngitis Tablets, by Country USD Million (2015-2020)
  • Figure 7. South America Pharyngitis Tablets Share (%), by Country
  • Table 16. South America Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 17. South America Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 18. South America Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 19. Brazil Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 20. Brazil Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 21. Brazil Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 22. Argentina Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 23. Argentina Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 24. Argentina Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 25. Rest of South America Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 26. Rest of South America Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 27. Rest of South America Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 28. Asia Pacific Pharyngitis Tablets, by Country USD Million (2015-2020)
  • Figure 8. Asia Pacific Pharyngitis Tablets Share (%), by Country
  • Table 29. Asia Pacific Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 30. Asia Pacific Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 31. Asia Pacific Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 32. China Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 33. China Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 34. China Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 35. Japan Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 36. Japan Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 37. Japan Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 38. India Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 39. India Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 40. India Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 41. South Korea Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 42. South Korea Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 43. South Korea Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 44. Taiwan Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 45. Taiwan Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 46. Taiwan Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 47. Australia Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 48. Australia Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 49. Australia Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 50. Rest of Asia-Pacific Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 51. Rest of Asia-Pacific Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 52. Rest of Asia-Pacific Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 53. Europe Pharyngitis Tablets, by Country USD Million (2015-2020)
  • Figure 9. Europe Pharyngitis Tablets Share (%), by Country
  • Table 54. Europe Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 55. Europe Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 56. Europe Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 57. Germany Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 58. Germany Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 59. Germany Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 60. France Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 61. France Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 62. France Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 63. Italy Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 64. Italy Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 65. Italy Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 66. United Kingdom Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 67. United Kingdom Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 68. United Kingdom Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 69. Netherlands Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 70. Netherlands Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 71. Netherlands Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 72. Rest of Europe Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 73. Rest of Europe Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 74. Rest of Europe Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 75. MEA Pharyngitis Tablets, by Country USD Million (2015-2020)
  • Figure 10. MEA Pharyngitis Tablets Share (%), by Country
  • Table 76. MEA Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 77. MEA Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 78. MEA Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 79. Middle East Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 80. Middle East Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 81. Middle East Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 82. Africa Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 83. Africa Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 84. Africa Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 85. North America Pharyngitis Tablets, by Country USD Million (2015-2020)
  • Figure 11. North America Pharyngitis Tablets Share (%), by Country
  • Table 86. North America Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 87. North America Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 88. North America Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 89. United States Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 90. United States Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 91. United States Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 92. Canada Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 93. Canada Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 94. Canada Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Table 95. Mexico Pharyngitis Tablets, by Distribution Channel USD Million (2015-2020)
  • Table 96. Mexico Pharyngitis Tablets, by Source USD Million (2015-2020)
  • Table 97. Mexico Pharyngitis Tablets, by Symptoms USD Million (2015-2020)
  • Figure 12. Global Pharyngitis Tablets share by Players 2020 (%)
  • Figure 13. Global Pharyngitis Tablets share by Players (Top 3) 2020(%)
  • Figure 14. Global Pharyngitis Tablets share by Players (Top 5) 2020(%)
  • Table 98. Company Basic Information, Sales Area and Its Competitors
  • Table 99. Company Basic Information, Sales Area and Its Competitors
  • Table 100. Company Basic Information, Sales Area and Its Competitors
  • Table 101. Company Basic Information, Sales Area and Its Competitors
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Pharyngitis Tablets: by Distribution Channel(USD Million)
  • Figure 36. Global Pharyngitis Tablets: by Distribution Channel USD Million (2021-2026)
  • Table 109. Pharyngitis Tablets Hospitals , by Region USD Million (2021-2026)
  • Table 110. Pharyngitis Tablets Retail Pharmacies , by Region USD Million (2021-2026)
  • Table 111. Pharyngitis Tablets Online Pharmacies , by Region USD Million (2021-2026)
  • Table 112. Pharyngitis Tablets: by Source(USD Million)
  • Figure 37. Global Pharyngitis Tablets: by Source USD Million (2021-2026)
  • Table 113. Pharyngitis Tablets Viral , by Region USD Million (2021-2026)
  • Table 114. Pharyngitis Tablets Bacterial , by Region USD Million (2021-2026)
  • Table 115. Pharyngitis Tablets: by Symptoms(USD Million)
  • Figure 38. Global Pharyngitis Tablets: by Symptoms USD Million (2021-2026)
  • Table 116. Pharyngitis Tablets Sore Throat , by Region USD Million (2021-2026)
  • Table 117. Pharyngitis Tablets Fever , by Region USD Million (2021-2026)
  • Table 118. Pharyngitis Tablets Runny Nose , by Region USD Million (2021-2026)
  • Table 119. Pharyngitis Tablets Cough , by Region USD Million (2021-2026)
  • Table 120. Pharyngitis Tablets Headache , by Region USD Million (2021-2026)
  • Table 121. Pharyngitis Tablets Hoarse Voice , by Region USD Million (2021-2026)
  • Table 122. South America Pharyngitis Tablets, by Country USD Million (2021-2026)
  • Figure 39. South America Pharyngitis Tablets Share (%), by Country
  • Table 123. South America Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 124. South America Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 125. South America Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 126. Brazil Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 127. Brazil Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 128. Brazil Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 129. Argentina Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 130. Argentina Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 131. Argentina Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 132. Rest of South America Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 133. Rest of South America Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 134. Rest of South America Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 135. Asia Pacific Pharyngitis Tablets, by Country USD Million (2021-2026)
  • Figure 40. Asia Pacific Pharyngitis Tablets Share (%), by Country
  • Table 136. Asia Pacific Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 137. Asia Pacific Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 138. Asia Pacific Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 139. China Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 140. China Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 141. China Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 142. Japan Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 143. Japan Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 144. Japan Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 145. India Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 146. India Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 147. India Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 148. South Korea Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 149. South Korea Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 150. South Korea Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 151. Taiwan Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 152. Taiwan Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 153. Taiwan Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 154. Australia Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 155. Australia Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 156. Australia Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 157. Rest of Asia-Pacific Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 158. Rest of Asia-Pacific Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 159. Rest of Asia-Pacific Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 160. Europe Pharyngitis Tablets, by Country USD Million (2021-2026)
  • Figure 41. Europe Pharyngitis Tablets Share (%), by Country
  • Table 161. Europe Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 162. Europe Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 163. Europe Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 164. Germany Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 165. Germany Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 166. Germany Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 167. France Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 168. France Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 169. France Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 170. Italy Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 171. Italy Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 172. Italy Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 173. United Kingdom Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 174. United Kingdom Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 175. United Kingdom Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 176. Netherlands Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 177. Netherlands Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 178. Netherlands Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 179. Rest of Europe Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 180. Rest of Europe Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 181. Rest of Europe Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 182. MEA Pharyngitis Tablets, by Country USD Million (2021-2026)
  • Figure 42. MEA Pharyngitis Tablets Share (%), by Country
  • Table 183. MEA Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 184. MEA Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 185. MEA Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 186. Middle East Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 187. Middle East Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 188. Middle East Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 189. Africa Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 190. Africa Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 191. Africa Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 192. North America Pharyngitis Tablets, by Country USD Million (2021-2026)
  • Figure 43. North America Pharyngitis Tablets Share (%), by Country
  • Table 193. North America Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 194. North America Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 195. North America Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 196. United States Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 197. United States Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 198. United States Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 199. Canada Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 200. Canada Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 201. Canada Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 202. Mexico Pharyngitis Tablets, by Distribution Channel USD Million (2021-2026)
  • Table 203. Mexico Pharyngitis Tablets, by Source USD Million (2021-2026)
  • Table 204. Mexico Pharyngitis Tablets, by Symptoms USD Million (2021-2026)
  • Table 205. Research Programs/Design for This Report
  • Table 206. Key Data Information from Secondary Sources
  • Table 207. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. GSK group of companies (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 17. GSK group of companies (United Kingdom) Revenue: by Geography 2020
  • Figure 18. Pfizer Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 19. Pfizer Inc. (United States) Revenue: by Geography 2020
  • Figure 20. Genentech Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 21. Genentech Inc. (United States) Revenue: by Geography 2020
  • Figure 22. McNeil (United States) Revenue, Net Income and Gross profit
  • Figure 23. McNeil (United States) Revenue: by Geography 2020
  • Figure 24. Adamas Pharmaceutical Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 25. Adamas Pharmaceutical Inc. (United States) Revenue: by Geography 2020
  • Figure 26. PLIVA HRVATSKA d.o.o. (Croatia) Revenue, Net Income and Gross profit
  • Figure 27. PLIVA HRVATSKA d.o.o. (Croatia) Revenue: by Geography 2020
  • Figure 28. Valeant Pharmaceuticals International, Inc. (Canada) Revenue, Net Income and Gross profit
  • Figure 29. Valeant Pharmaceuticals International, Inc. (Canada) Revenue: by Geography 2020
  • Figure 30. Mylan N.V. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Mylan N.V. (United States) Revenue: by Geography 2020
  • Figure 32. Teva Pharmaceutical Industries Ltd. (Israel) Revenue, Net Income and Gross profit
  • Figure 33. Teva Pharmaceutical Industries Ltd. (Israel) Revenue: by Geography 2020
  • Figure 34. AbbVie Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 35. AbbVie Inc. (United States) Revenue: by Geography 2020
Some of the key companies/manufacturers profiled in the report
  • GSK group of companies (United Kingdom)
  • Pfizer Inc. (United States)
  • Genentech Inc. (United States)
  • McNeil (United States)
  • Adamas Pharmaceutical Inc. (United States)
  • PLIVA HRVATSKA d.o.o. (Croatia)
  • Valeant Pharmaceuticals International, Inc. (Canada)
  • Mylan N.V. (United States)
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • AbbVie Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation